Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEJAP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,629
Award facts
- Contract value 100% obligated
- $17,628.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $17,628.86 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 14, 2026, with an ultimate completion date of January 16, 2026, carries no set-aside designation and represents a single award with no identified subcontractors. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to federal agencies, particularly the Department of Defense, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medications.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy supporting Department of Defense healthcare operations globally. The underlying PPV-G GEN V contract, awarded on November 13, 2025, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to provide recurring medical supply products to military healthcare facilities worldwide. The company's established performance on numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system through firm fixed-price offerings.
Quick answers
Who was awarded contract SPE2DU26FEJAP?
SPE2DU26FEJAP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DU26FEJAP worth?
The government has obligated $17,629 on SPE2DU26FEJAP.
Is contract SPE2DU26FEJAP an order under another contract?
Yes. SPE2DU26FEJAP is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEJAP competed?
The extent of competition for SPE2DU26FEJAP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award